It’s Decathlon Time!

John Osbon - April 30, 2014

150 athletes. 10 events. One great cause. That’s the RBC Decathlon, a long summer day of running, throwing, lifting and jumping for the benefit of Memorial Sloan-Kettering Cancer Center. We’ll be there, and you can help.

Max has participated in this phenomenal event for the last two years. I joined the fun in 2013. And we’re both looking forward to the 2014 event at St John’s University on June 22. We’ve been training for months and will be ready to leave it all on the field in about six weeks.

Max OsbonThe 150 participants, all men and women from the financial services industry, will test their strength and fortitude in 10 events – 400 meter run, football throw, pull ups, 40 yard dash, dips, 500 meter row, vertical jump, agility course, bench press, and 800 meter run. Points are accumulated in each event to crown the champs.

It’s one of those great experiences that pushes you physically and mentally. I was honored to train side by side last winter with Max last year. He whipped me into great shape and we both met and exceeded our goals on the field. In an extremely strong field, Max missed 1st place in the 800 meter run by one slim second. It was wonderful to share the experience with Max and we’re ready for more this year.

And we’re excited to raise money for Sloan-Kettering too. Last year the event raised more than $1.4 million for cancer research, or almost $10,000 per participant. As organizers cover all the costs of running the event, 100 percent of all donations go directly to pediatric cancer research.

Support Team OsbonJohn Osbon

We humbly ask for your support. Click on the links below to support Max or me in our fundraising efforts. The Decathlon’s innovative CharityBets system lets you contribute a flat amount, or place bets on our performance. The better we do in our designated events, the greater your contribution. My CharityBet is on pull-ups. Max is looking for 59 seconds in the 400 meter run.

Thank you for considering a donation. We greatly appreciate the support as we hope to make a difference in cancer research. Oh, and by the way, we’re very proud to be representing the great city of Boston in a field composed almost entirely of New Yorkers. Need we say more?

Support Max Osbon

Support John Osbon

Print Friendly, PDF & Email

Disclaimer

  • This communication may include forward-looking statements. All statements other than statements of historical fact are forward-looking statements (including words such as “believe,” “estimate,” “anticipate,” “may,” “will,” “should,” and “expect”). Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. Various factors could cause actual results or performance to differ materially from those discussed in such forward-looking statements.”
  • “Historical performance is not indicative of future results. The investment return will fluctuate with market conditions.
  • Past performance is not indicative of any specific investment or future results. Views regarding the economy, securities markets or other specialized areas, like all predictors of future events, cannot be guaranteed to be accurate and may result in economic loss to the investor.
  • Investment strategies, philosophies, allocations and holdings are subject to change without prior notice.
  • This communication is intended to provide general information only and should not be construed as an offer of specifically tailored individualized advice.
  • While the Adviser believes the outside data sources cited to be credible, it has not independently verified the correctness of any of their inputs or calculations and, therefore, does not warranty the accuracy of any third-party sources or information.
  • Adviser does not endorse the statements, services or performance of any third-party vendor.
  • Unless stated otherwise, any mention of specific securities or investments is for hypothetical and illustrative purposes only. Adviser’s clients may or may not hold the securities discussed in their portfolios. Adviser makes no representations that any of the securities discussed have been or will be profitable.